Active substance
Ticlopidine
- SFDA 3
- US FDA 10
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| PREVOC 250 MG FILM COATED TABLETS | 250 mg | Film-coated tablet · Oral use | 20 Blister | SAR 38.40 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC | Withdrawn by MAH · Not Marketed |
| TICLID 250MG TAB | 250 mg | Tablet · Oral use | 20 Blister | SAR 66.35 | NCE · Prescription | sanofi-aventis | Withdrawn by MAH · Not Marketed |
| TICOPAR 250 MG F-C TABLETS | 250 mg | Film-coated tablet · Oral use | 20 Blister | SAR 46.45 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TICLID | 125MG; 250MG | tablet · oral | ROCHE PALO | Discontinued | 31 Oct 1991 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | APOTEX | Discontinued | 1 Jul 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | TEVA | Discontinued | 20 Aug 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | ACTAVIS ELIZABETH | Discontinued | 20 Aug 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | CHARTWELL RX | Discontinued | 20 Aug 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | CHARTWELL RX | Discontinued | 20 Aug 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | MYLAN | Discontinued | 13 Sep 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | NATCO PHARMA | Discontinued | 2 Nov 1999 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | WATSON LABS | Discontinued | 26 Apr 2000 |
| TICLOPIDINE HYDROCHLORIDE | 250MG | tablet · oral | SUN PHARM INDS INC | Discontinued | 26 Sep 2002 |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.